» Articles » PMID: 26573884

Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2015 Nov 18
PMID 26573884
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Nausea and vomiting are a frequent accompaniment of migraine and anti-nausea medications are frequently used in its management. The majority of anti-nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug-induced movement disorders. This article explores the risk of such drug-induced movement disorders in migraineurs who were treated with these medications.

Citing Articles

The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.

Kirsten C, Catthoor K, Detraux J, Johan D, De Hert M Eur Psychiatry. 2025; 68(1):e36.

PMID: 39925222 PMC: 11883798. DOI: 10.1192/j.eurpsy.2025.18.


Akathisia and oculogyric crisis in hyperemesis gravidarum.

Morton A, Mackle C, Pavey J Obstet Med. 2024; 17(2):129-131.

PMID: 38784181 PMC: 11110745. DOI: 10.1177/1753495X221137942.


Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?.

Gibler R, Knestrick K, Reidy B, Lax D, Powers S Pediatric Health Med Ther. 2022; 13:309-323.

PMID: 36110896 PMC: 9470380. DOI: 10.2147/PHMT.S334744.


Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report.

Sakamoto S, Deguchi Y, Uchida S, Itoh Y, Inoue K Neuropsychopharmacol Rep. 2022; 42(3):380-383.

PMID: 35716124 PMC: 9515702. DOI: 10.1002/npr2.12277.


Metoclopramide induced acute dystonic reaction: A case report.

Sheikh Hassan M, Nor M Ann Med Surg (Lond). 2022; 74:103248.

PMID: 35070292 PMC: 8761935. DOI: 10.1016/j.amsu.2022.103248.